ReviewClinical pharmacology and therapeutics2019

Trials in "True" Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk.

José P Werba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.